Drug intelligence / Profile preview

1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene

Development stage: Unknown
Modality: Small Molecules

Overview

1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene is a synthetic small molecule with the chemical formula C10H11F3N4S and a molecular weight of approximately 276.28 g/mol. It is classified as an experimental compound, and there is no evidence of clinical use or approval for any therapeutic indication. The structure features a trifluoromethyl-substituted benzene ring linked via a sulfanylmethyl group to an imino-guanidine moiety. No detailed pharmacological data, mechanism of action, or biological target information are available in public databases as of June 2025[1][2].

Beyond the preview

Go deeper on 1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene.

Explore the full profile